New modalities of allergen immunotherapy

Manish Ramesh, Merhunisa Karagic

Research output: Contribution to journalReview article

Abstract

Allergen immunotherapy is a rapidly evolving field. Although subcutaneous immunotherapy has been practiced for over a hundred years, improved understanding of the underlying immunological mechanisms has led to the development of new, efficacious and better tolerated allergen-derivatives, adjuvants and encapsulated allergens. Diverse routes of allergen immunotherapy–oral, sublingual, epicutanoeus and intralymphatic–are enabling immunotherapy for anaphylactic food allergies and pollen-food allergy syndrome, while improving the tolerability and effectiveness of aeroallergen immunotherapy. The addition of Anti-IgE therapy decreases adverse effects of subcutaneous and oral immunotherapy.

Original languageEnglish (US)
Pages (from-to)2848-2863
Number of pages16
JournalHuman Vaccines and Immunotherapeutics
Volume14
Issue number12
DOIs
StatePublished - Dec 2 2018

Fingerprint

Immunologic Desensitization
Immunotherapy
Allergens
Food Hypersensitivity
Seasonal Allergic Rhinitis

Keywords

  • adjuvants
  • Allergen Immunotherapy
  • Anti-IgE
  • Epicutaneous Immunotherapy
  • Oral Immunotherapy
  • Subcutaneous Immunotherapy
  • Sublingual Immunotherapy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

New modalities of allergen immunotherapy. / Ramesh, Manish; Karagic, Merhunisa.

In: Human Vaccines and Immunotherapeutics, Vol. 14, No. 12, 02.12.2018, p. 2848-2863.

Research output: Contribution to journalReview article

Ramesh, Manish ; Karagic, Merhunisa. / New modalities of allergen immunotherapy. In: Human Vaccines and Immunotherapeutics. 2018 ; Vol. 14, No. 12. pp. 2848-2863.
@article{df4002a6311142aca8d0e0c05653d340,
title = "New modalities of allergen immunotherapy",
abstract = "Allergen immunotherapy is a rapidly evolving field. Although subcutaneous immunotherapy has been practiced for over a hundred years, improved understanding of the underlying immunological mechanisms has led to the development of new, efficacious and better tolerated allergen-derivatives, adjuvants and encapsulated allergens. Diverse routes of allergen immunotherapy–oral, sublingual, epicutanoeus and intralymphatic–are enabling immunotherapy for anaphylactic food allergies and pollen-food allergy syndrome, while improving the tolerability and effectiveness of aeroallergen immunotherapy. The addition of Anti-IgE therapy decreases adverse effects of subcutaneous and oral immunotherapy.",
keywords = "adjuvants, Allergen Immunotherapy, Anti-IgE, Epicutaneous Immunotherapy, Oral Immunotherapy, Subcutaneous Immunotherapy, Sublingual Immunotherapy",
author = "Manish Ramesh and Merhunisa Karagic",
year = "2018",
month = "12",
day = "2",
doi = "10.1080/21645515.2018.1502126",
language = "English (US)",
volume = "14",
pages = "2848--2863",
journal = "Human Vaccines and Immunotherapeutics",
issn = "2164-5515",
publisher = "Landes Bioscience",
number = "12",

}

TY - JOUR

T1 - New modalities of allergen immunotherapy

AU - Ramesh, Manish

AU - Karagic, Merhunisa

PY - 2018/12/2

Y1 - 2018/12/2

N2 - Allergen immunotherapy is a rapidly evolving field. Although subcutaneous immunotherapy has been practiced for over a hundred years, improved understanding of the underlying immunological mechanisms has led to the development of new, efficacious and better tolerated allergen-derivatives, adjuvants and encapsulated allergens. Diverse routes of allergen immunotherapy–oral, sublingual, epicutanoeus and intralymphatic–are enabling immunotherapy for anaphylactic food allergies and pollen-food allergy syndrome, while improving the tolerability and effectiveness of aeroallergen immunotherapy. The addition of Anti-IgE therapy decreases adverse effects of subcutaneous and oral immunotherapy.

AB - Allergen immunotherapy is a rapidly evolving field. Although subcutaneous immunotherapy has been practiced for over a hundred years, improved understanding of the underlying immunological mechanisms has led to the development of new, efficacious and better tolerated allergen-derivatives, adjuvants and encapsulated allergens. Diverse routes of allergen immunotherapy–oral, sublingual, epicutanoeus and intralymphatic–are enabling immunotherapy for anaphylactic food allergies and pollen-food allergy syndrome, while improving the tolerability and effectiveness of aeroallergen immunotherapy. The addition of Anti-IgE therapy decreases adverse effects of subcutaneous and oral immunotherapy.

KW - adjuvants

KW - Allergen Immunotherapy

KW - Anti-IgE

KW - Epicutaneous Immunotherapy

KW - Oral Immunotherapy

KW - Subcutaneous Immunotherapy

KW - Sublingual Immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=85067247163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067247163&partnerID=8YFLogxK

U2 - 10.1080/21645515.2018.1502126

DO - 10.1080/21645515.2018.1502126

M3 - Review article

C2 - 30183485

AN - SCOPUS:85067247163

VL - 14

SP - 2848

EP - 2863

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

SN - 2164-5515

IS - 12

ER -